Efficacy and Tolerability of Dydrogesterone and Intravaginal Progesterone in the Luteal Phase Support.

Trial Profile

Efficacy and Tolerability of Dydrogesterone and Intravaginal Progesterone in the Luteal Phase Support.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2015

At a glance

  • Drugs Dydrogesterone (Primary) ; Progesterone (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Sep 2011 Planned End Date changed from 1 Oct 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 28 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top